Search research articles
Contact Us
Filters
Showing results (91-100 of 130) with videos related to
Page
of 13
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 26, 2010
Endogenous purinergic control of bladder activity via presynaptic P2X3 and P2X2/3 receptors in the spinal cord
Timothy K Y Kaan, Ping K Yip, John Grist, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 3, 2014
Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice
Markus Huber-Lang, Andreas Barratt-Due, Søren E Pischke, et al.
Pediatric Diabetes
|
March 16, 2004
Insulin lispro versus regular insulin in children with type 1 diabetes on twice daily insulin
J M Fairchild, G R Ambler, C H Genoud-Lawton, et al.
Bone Marrow Transplantation
|
November 1, 2006
Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors
J M Hows, J R Passweg, A Tichelli, et al.
Bioconjugate Chemistry
|
January 12, 2019
Targeting Fluorescent Nanodiamonds to Vascular Endothelial Growth Factor Receptors in Tumor
Marco D Torelli, Ashlyn G Rickard, Marina V Backer, et al.
Immunobiology
|
May 10, 2015
Organ inflammation in porcine Escherichia coli sepsis is markedly attenuated by combined inhibition of C5 and CD14
Kjetil H Egge, Ebbe B Thorgersen, Søren E Pischke, et al.
JCI Insight
|
August 9, 2019
Dual inhibition of complement factor 5 and leukotriene B4 synergistically suppresses murine pemphigoid disease
Tanya Sezin, Sripriya Murthy, Claudia Attah, et al.
Neuroscience Letters
|
November 26, 2008
The role of metabotropic glutamate receptor mGlu5 in control of micturition and bladder nociception
Youmin Hu, Li Dong, Biying Sun, et al.
Clinical and Translational Science
|
November 1, 2021
Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168)
Timothy D Owens, Patrick F Smith, Andrew Redfern, et al.
The Journal of Urology
|
June 23, 2009
Selective pharmacological blockade of the TRPV1 receptor suppresses sensory reflexes of the rodent bladder
Joseph S Cefalu, Marlene A Guillon, Leah R Burbach, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 130) with videos related to
Sort By:
Page
of 13
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 26, 2010
Endogenous purinergic control of bladder activity via presynaptic P2X3 and P2X2/3 receptors in the spinal cord
Timothy K Y Kaan, Ping K Yip, John Grist, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 3, 2014
Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice
Markus Huber-Lang, Andreas Barratt-Due, Søren E Pischke, et al.
Pediatric Diabetes
|
March 16, 2004
Insulin lispro versus regular insulin in children with type 1 diabetes on twice daily insulin
J M Fairchild, G R Ambler, C H Genoud-Lawton, et al.
Bone Marrow Transplantation
|
November 1, 2006
Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors
J M Hows, J R Passweg, A Tichelli, et al.
Bioconjugate Chemistry
|
January 12, 2019
Targeting Fluorescent Nanodiamonds to Vascular Endothelial Growth Factor Receptors in Tumor
Marco D Torelli, Ashlyn G Rickard, Marina V Backer, et al.
Immunobiology
|
May 10, 2015
Organ inflammation in porcine Escherichia coli sepsis is markedly attenuated by combined inhibition of C5 and CD14
Kjetil H Egge, Ebbe B Thorgersen, Søren E Pischke, et al.
JCI Insight
|
August 9, 2019
Dual inhibition of complement factor 5 and leukotriene B4 synergistically suppresses murine pemphigoid disease
Tanya Sezin, Sripriya Murthy, Claudia Attah, et al.
Neuroscience Letters
|
November 26, 2008
The role of metabotropic glutamate receptor mGlu5 in control of micturition and bladder nociception
Youmin Hu, Li Dong, Biying Sun, et al.
Clinical and Translational Science
|
November 1, 2021
Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168)
Timothy D Owens, Patrick F Smith, Andrew Redfern, et al.
The Journal of Urology
|
June 23, 2009
Selective pharmacological blockade of the TRPV1 receptor suppresses sensory reflexes of the rodent bladder
Joseph S Cefalu, Marlene A Guillon, Leah R Burbach, et al.
Page
of 13